文献速递重症综合管理与镇静镇痛

ICU血小板输注实践:前瞻性多中心队列研究

Platelet Transfusion Practices in the ICU: A Prospective Multicenter Cohort Study.
PubMed 文献 · Crit Care Med · 2025-09-25
一句话结论国际多中心队列显示ICU中6%患者接受血小板输注,主要适应证为活动性出血(42%)和预防性输注(33%),输注前中位血小板计数44×10⁹/L,51%事件有明确阈值但16%未遵循。

该国际前瞻性队列研究纳入30个国家233个中心ICU中3643例成人患者,评估血小板输注发生率、适应证、阈值及地域差异。结果显示6%(208例)接受血小板输注,主要适应证为活动性出血(42%)、预防性输注(33%)和即将进行的手术(12%)。输注前中位血小板计数44×10⁹/L(IQR 20-78),活动性出血时中位数为60×10⁹/L(IQR 31-93)。51%事件报告了输注阈值(中位50×10⁹/L,IQR 40-100),16%未遵循所建议阈值。不同地域经济区域间输注实践存在差异:高收入国家6%、中高收入国家5%、中低收入国家0%。

要点

  • ICU中6%(208/3643)患者接受血小板输注,主要适应证为活动性出血(42%)和预防性输注(33%)。
  • 输注前中位血小板计数44×10⁹/L(IQR 20-78),活动性出血时更高为60×10⁹/L(IQR 31-93)。
  • 51%输注事件有明确阈值(中位50×10⁹/L,IQR 40-100),16%(36/224)未遵循建议阈值,多数为活动性出血。
  • 高收入国家输注率6%(156/2520)vs 中高收入国家5%(52/1069)vs 中低收入国家0%(0/54)。
  • 不遵循阈值在高收入国家更高(23%,34/149)vs 中高收入国家(3%,2/75)。

适用人群与场景

  • 18岁及以上成人ICU患者,来自30个国家233个中心,研究周为2019年3月至2022年10月间16个预设周之一。

研究设计与关键结果

  • 国际前瞻性队列研究,纳入3643例ICU成人患者,208例(6%)接受血小板输注。
  • 主要适应证:活动性出血42%(187/443)、预防性输注33%(144/443)、即将进行的手术12%(51/443)。
  • 输注前中位血小板计数44×10⁹/L(IQR 20-78),活动性出血时中位60×10⁹/L(IQR 31-93)。
  • 51%(224/443)输注事件报告阈值,中位阈值50×10⁹/L(IQR 40-100);16%(36/224)未遵循建议阈值,多数为活动性出血。
  • 高收入国家输注率6%(156/2520),中高收入国家5%(52/1069),中低收入国家0%(0/54)。
  • 不遵循阈值:高收入国家23%(34/149)vs 中高收入国家3%(2/75)。

证据类型、等级与局限

  • 证据类型:国际前瞻性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: There is a lack of comprehensive international data regarding platelet transfusion practices in the ICU. This study aimed to evaluate the current occurrence rate of platelet transfusion in the ICU and provide an overview of platelet transfusion practices including indications for a platelet transfusion, thresholds, (non-)adherence and geo-economic region variations.

DESIGN: International prospective cohort study.

SETTING: Two hundred thirty-three centers in 30 countries worldwide.

PATIENTS: All patients 18 years old and older, admitted to the ICU during a single study week, selected by each site from one of the 16 predefined weeks (March 2019 to October 2022), were included.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Of the 3643 patients, 208 (6%) received a platelet transfusion during their ICU stay and main indications consisted of active bleeding (42%, n = 187/443), prophylaxis (33%, n = 144/443) or an upcoming procedure (12%, n = 51/443). The median platelet count before transfusion was 44 × 10 9 /L (interquartile range [IQR], 20-78) with variation by indication, including a higher median of 60 × 10 9 /L (IQR 31-93) during active bleeding. A threshold for transfusion was stated in 51% ( n = 224/443) of the events, with a median threshold platelet count of 50 × 10 9 /L (IQR, 40-100). The advised threshold was not adhered to in 16% ( n = 36/224) of cases, with the majority having active bleeding as indication. Contrasts in transfusion practices were observed across different geo-economic regions. Platelet transfusions were administered to 6% ( n = 156/2520) of patients in high-income countries, 5% ( n = 52/1069) of patients in upper-middle-income countries and in none from lower-middle-income countries ( n = 0/54). Non-adherence was higher in the high-income countries (23%, n = 34/149) than upper-middle-income countries (3%, n = 2/75).

CONCLUSIONS: Platelet transfusions were administered to a small proportion of critically ill patients, and were given to treat active bleeding or as prophylaxis in the majority of cases. Occurence rate, indication and threshold adherence for platelet transfusion widely varied between geo-economic regions.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. van Wonderen SF, Raasveld SJ, Flint AWJ, et al. Platelet Transfusion Practices in the ICU: A Prospective Multicenter Cohort Study. Crit Care Med. 2025. PMID: 41002230. doi:10.1097/CCM.0000000000006880

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。